MV
Manojkumar Vaijanathrao Bhutte
About Manojkumar Vaijanathrao Bhutte
Data last updated:
Manojkumar Vaijanathrao Bhutte is a Partner at Posilive Pharmaceuticals Llp (since 2014), Additional Director at Hubli Scan Centre Private Limited (since 2025) and Director at Fortuna Tradelinks Private Limited (since 2026), and holds 2 more current directorships. The companies operate in Pharma and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹22.53 Cr; the largest is Posilive Pharmaceuticals Llp at ₹11.66 Cr (FY 2022). Earlier, Manojkumar Vaijanathrao Bhutte was a Director at Health Secure Hospitals Private Limited (2021–2025) and Director at Health Secure Hospital Care & Solutions Private Limited (2021–2025) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Posilive Pharmaceuticals Llp AAC-8330 | Partner | 21 Oct 2014 | 2014 | ₹11.66 Cr (FY 2022) | Active |
 Hubli Scan Centre Private Limited U85110KA2001PTC029063 | Additional Director | 29 Jan 2025 | 2001 | ₹10.86 Cr (FY 2024) | Active |
| Fortuna Tradelinks Private Limited U68200KA2026PTC213755 | Director | 06 Jan 2026 | 2026 | Active | |
| Designated Partner | 20 Sep 2019 | 2019 | Active | ||
| Aaryavedanta Scan Centre Llp AAE-4252 | Designated Partner | 22 Jul 2015 | 2015 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Health Secure Hospitals Private Limited U85190KA2021PTC143563 | Director | 27 Jan 2021 | 2021 | ₹72.68 Cr (FY 2024) | Active |
| Health Secure Hospital Care & Solutions Private Limited U85110KA2004PTC035114 | Director | 29 Nov 2021 | 2004 | ₹72.63 Cr (FY 2024) | Active |
| Hubli Superspeciality Hospital Llp AAI-9648 | Designated Partner | 27 Mar 2017 | 2017 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Manojkumar Vaijanathrao Bhutte
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Manojkumar Vaijanathrao Bhutte
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Manojkumar Vaijanathrao Bhutte
Manojkumar Vaijanathrao Bhutte currently holds 5 directorships: Posilive Pharmaceuticals Llp (Partner, since 21 Oct 2014, revenue ₹11.66 Cr (FY 2022)); Hubli Scan Centre Private Limited (Additional Director, since 29 Jan 2025, revenue ₹10.86 Cr (FY 2024)); Fortuna Tradelinks Private Limited (Director, since 06 Jan 2026); Hubli Secure Multi Speciality Hospital Llp (Designated Partner, since 20 Sep 2019); Aaryavedanta Scan Centre Llp (Designated Partner, since 22 Jul 2015).
Manojkumar Vaijanathrao Bhutte was first appointed on 21 Oct 2014 as Partner at Posilive Pharmaceuticals Llp. The most recent appointment on record is 06 Jan 2026 at Fortuna Tradelinks Private Limited.
The 2 current companies of Manojkumar Vaijanathrao Bhutte that report revenue have a combined latest revenue of ₹22.53 Cr: Posilive Pharmaceuticals Llp ₹11.66 Cr (FY 2022); Hubli Scan Centre Private Limited ₹10.86 Cr (FY 2024).
Manojkumar Vaijanathrao Bhutte held 3 earlier board appointments: Health Secure Hospitals Private Limited (Director, 27 Jan 2021 to 05 Sep 2025); Health Secure Hospital Care & Solutions Private Limited (Director, 29 Nov 2021 to 01 Aug 2025); Hubli Superspeciality Hospital Llp (Designated Partner, 27 Mar 2017 to 24 Dec 2020).
The current boards of Manojkumar Vaijanathrao Bhutte's companies include Hedna Vishnumurthy Santhrupth (Posilive Pharmaceuticals Llp), Raghavendra Jayakumar Yencharla (Posilive Pharmaceuticals Llp), Abhijit Devaraj Hiregoudar (Hubli Scan Centre Private Limited), Aniruddha Ashok Kulkarni (Hubli Scan Centre Private Limited), Chandrakant Shrikant Katwe (Hubli Scan Centre Private Limited), Dattatraya Bhaskar Nadgir (Hubli Scan Centre Private Limited), among others.